UB Multiple Sclerosis Study Shows Promising Results

Preliminary results of a clinical study related to multiple sclerosis conducted by University at Buffalo researchers show promising results, leading investigators to plan more examinations with advanced diagnostic tools. The investigation is the first step in determining if a condition called chronic cerebrospinal venous insufficiency (CCSVI) is a major risk factor for MS.

Robert Zivadinov, UB associate professor of neurology and principal investigator on the study, says he is “cautiously optimistic and excited” about the preliminary data. Zivadinov directs the Buffalo Neuroimaging Analysis Center (BNAC), located in Kaleida Health’s Buffalo General Hospital, where the study is being conducted.

“The data encourage us to continue on the same course,” he says. “They show that narrowing of the extracranial veins, at the very least, is an important association in multiple sclerosis. We will know more when the MRI and other data collected in the CTEVD study are available.” The analyses are being conducted by an independent statistician. Read more.

Comments are closed.